| Home | | Inventure Capital | | Team | | Investments | | Portfolio | | News | | Contact |  |
NEWS
08-06-2010
Action Pharma obtains encouraging preliminary results in a phase II clinical trial with AP214
Holte, Denmark, June 7, 2010
Action Pharma A/S obtained encouraging preliminary blinded results in the second phase II clinical trial (named CS005) with its lead development candidate, AP214.
AP214 is being developed for protection of acute kidney injury in patients undergoing cardiac surgery under cardiopulmonary bypass as the lead indication. Read more
29-04-2010
Direktørskifte i Medotech indvarsler ekspansion
Den danske biotek virksomhed Medotech A/S, får pr. 1.juni ny administrerende direktør. Det bliver den 37-årige Thomas Sandholdt, der afløser Medotechs adm. direktør gennem fire år, Troels Bierman Mortensen. Direktørskiftet kommer efter, at Medotechs hovedprodukt, det dansk udviklede Grindcare apparat til at diagnosticere og behandle tænderskæren med, netop er blevet godkendt af de amerikanske sundhedsmyndigheder, FDA.
Read more
20-04-2010
Stejl salgskurve i teknologivirksomheden Proxeon førte til amerikansk salg
AF JENS BERTELSEN
Solgt
Et ukendt millionbeløb går nu ind på kontoen hos de tre venturefonde Inventure Capital, Vecata og Vækstfonden, som i går kunne gennemføre årets første venture-exit herhjemme. Teknologivirksomheden Proxeon i Odense blev solgt til den amerikanske life science-gigant Thermo Fisher Scientific efter at have dokumenteret en kraftig vækst i salget sidste år.
Read more
16-04-2010
Vækstfonden og to ventureselskaber sælger fynske Proxeon til amerikansk life-science-koncern.
Read more16-04-2010
Den odenseanske virksomhed Proxeon, der har haft succes med at lave udstyr til medicinalindustrien, er blevet solgt til amerikanske Thermo Fischer Scientific
Read more16-04-2010
Venturefondene Inventure Capital, Vecata og Vækstfonden kan i dag torsdag offentliggøre salget af den odensebaserede life science-virksomhed Proxeon. Virksomheden er solgt til amerikanske Thermo Fisher Scientific, en af verdens førende life science-virksomheder, efter at have mere end fordoblet sin omsætning til 50 millioner kroner i 2009. Salget er det første danske venturesalg i år.
Read more12-04-2010
Action Pharma completes dosing in phase II clinical trial with AP214 to prevent acute kidney injury associated with cardiac surgery
Action Pharma A/S has completed dosing in the second phase II clinical trial with its leading development candidate, AP214. Interim efficacy data are expected June 2010. AP214 is being developed for protection of acute kidney injury in patients undergoing cardiac surgery under cardiopulmonary bypass as the lead indication.
Read more
23-03-2010
Medotech på jagt efter millioner
Efter at Medotech fra Århus har fået sit apparat mod tænderskæren godkendt til markedsføring i USA, søger firmaet en ny investor, der kan bidrage med 15-20 mio. kr. til lanceringen.
Read more
17-03-2010
Fluxome and GlycaNova join forces to bring a promising beta glucan product to the US dietary supplement market
Nutraceutical ingredient provider, Fluxome A/S has entered a strategic exclusivity agreement with research-based biotechnology company GlycaNova Norway AS. Fluxome gains the exclusive rights from GlycaNova to market and sell a very promising beta glucan product in the US dietary supplement market. Read more
05-02-2010
Proxeon i Odense har fået gang i salget og forventer overskud efter en årrække med store tab.
Read more01-02-2010
Inventure Capital og Connect Denmark gå-hjem møde
Onsdag d. 24. februar 2010 inviterer Inventure Capital og Connect Denmark til gå-hjem møde om emnet - "Hvordan ser verden ud i dag" Read more
08-01-2010
Din hovedpine kan skyldes, at du skærer tænder om natten
Mange har symptomer uden at vide det, fordi de skærer tænder om natten, mener professor ved tandlægeskolen i Århus. Tænderskæren er en overset årsag til en række lidelser, der forringer livskvaliteten. Read more
08-01-2010
Tænderskæren er en overset årsag til en række lidelser, der forringer livskvaliteten. Det skriver 24timer.
Read more04-01-2010
Århus-selskab bag ny cleantech-fond
Inventure Capital forventre at etablere en fond med 300-400 mio. kr. i både offentlige og private penge til investeringer i løbet af foråret 2010. Read more
17-12-2009
Århusiansk ventureselskab prækvalificeret til at skabe ny landsdækkende cleantech-venturefond
Ventureselskabet Inventure Capital er netop blevet prækvalificeret af Vækstfonden til at modtage op til 175 millioner kroner fra regeringens Erhvervspakke. Prækvalifikationen betyder, at Inventure Capital kan oprette en ny venturefond for cleantech, som kan hjælpe små, danske cleantech-selskaber på vej. Read more
23-11-2009
Inventure Capitals porteføljeselskaber stærkt repræsenteret i årets Entrepreneur of the Year-konkurrence.
Managementselskabet Inventure Capital var stærkt repræsenteret, da årets Entrepreneurs of the Year torsdag blev udnævnt af Ernst & Young. Vinderen i kategorien Life Sciences/Biotech blev Inventure Capitals porteføljeselskab Medotech. Inventure Capital havde derudover yderligere fire porteføljeselskaber nomineret i kategorien. Read more
23-11-2009
Medotech A/S vinder Entrepreneur Of The Year
Dansk biotech virksomhed, der har udviklet epokegørende metode til at behandle bruksisme, vinder i kategorien LifeSciences.
Den danske biotech virksomhed Medotech A/S, der producerer teknologiske løsninger til mennesker, der skærer tænder, er vinder af dette års Entrepreneur Of The Year inden for kategorien Life Sciences. Kåringen af Medotech fandt sted torsdag aften i Bella Center i København under et awardshow med godt 700 deltagere fra hele landet. Read more
23-11-2009
We are proud to announce that Fluxome A/S was nominated to become Entrepreneur of the Year 2009.
Read more16-11-2009
Teeth grinders are in for a shock.
Patients complaining of grinding their teeth in their sleep are being given mild electric shock treatment.
A chain of private dental practices in Hull is trialling a device which delivers a tiny electrical impulse when it detects grinding is about to begin. Read more
02-11-2009
Fluxome opens sales office for the North American market and appoints Dr Herbert Woolf as CEO and PRESIDENT of the new subsidiary
The good response from the market for Fluxome's first commercial product, natural trans-resveratrol, is embraced by the company with the opening of a sales office in New Jersey. The sales office will be headed by Dr Herb Woolf, who with his +25 years in the industry, brings an experienced perspective of the importance of product safety, purity and quality, as well as consistency of supply as the key success factors for commercial success. Read more
21-10-2009
Action Pharma in new phase II clinical trial
Action Pharma has initiated a new clinical phase II trial for it’s leading development candidate
AP214, investigating the effect of AP214 on organ protection in patients undergoing cardiac
surgery, who are at increased risk of kidney injury. The clinical trial has been launched in
Denmark at “Rigshospitalet”.
Read more
05-10-2009
I samarbejde med Inventure Capital inviterer DVCA til gå-hjem-møde om "Successful Business Models of Capital Efficiency - 2 Case Studies blandt Inventure Capitals porteføljevirksomheder"
Mødet afholdes d. 27. oktober 2009 kl. 16.00 – 18.00 hos Inventure Capital, Nørreport 26, 2. - 8000 Århus C
Read more
05-10-2009
Proxeon expands commercial operations in Europe and Asia-Pacific
Proxeon confirmed today that the company is significantly expanding its sales and marketing network in Europe and Asia-Pacific, having signed six new distribution agreements.
Expansion of the distribution network in Europe means that Proxeon products will be represented by Proteomic Solutions in France, Rigas Labs S.A. in Greece and Biosense Srl. in Italy. Philippe Dutriat, Director of Proteomic Solutions, established in France since 2001, explained his reasons for the partnership, "Proxeon already had a solid reputation for its nano ES ion sources that were sold under the Protana company name in France. Read more
15-09-2009
aCon A/S wins an EU tender and will deliver 30 advanced self-service units to Post Danmark A/S.
Read more26-06-2009
Indslag i P1 Business d. 18. juni 2009 vedrørende finansiering af vækstiværksættervirksomheder, hvor FCMB er nævt som eksempel.
Read more08-06-2009
Afvikling af InnFond P/S
De to limited partners i InnFond K/S, Vækstfonden og Novi A/S har besluttet at afvikle InnFond P/S. Fondens tilbageværende aktiver deles mellem parterne og Inventure Capital A/S er således ikke længere managementselskab for InnFond P/S. NOVI A/S og Vækstfonden driver porteføljevirksomhederne videre i hver deres eget regi.
Read more
02-06-2009
Dansk udviklingsvirksomhed får gennembrud i jagten på en afløser til fostervandsprøver
Read more02-06-2009
Medotech har trods finanskrise hentet 30 mio. kr. i frisk kapital til
den globale lancering af selskabets medicinske apparat, der behandler tænderskæren Read more
28-05-2009
Danske forskere kan finde kromosomfejl hos fostre ved hjælp af en blodprøve tidligt i graviditeten frem for ved en risikabel moderkageprøve. Dermed kan en række ufrivillige aborter undgås
Read more26-05-2009
Dansk biotekselskab har isoleret fosterceller i gravides blod. Dermed vil kromosomfejl som Downs syndrom kunne afsløres uden risikable fostervandsprøver.
Read more06-05-2009
Proxeon's EASY-nLC enables discovery of oldest protein sequences ever acquired.
Odense, Denmark, 5 May 2009. Proxeon's EASY-nLC, together with a Thermo Orbitrap XL, has been used to successfully analyze ancient protein dating back 80 million years. Read more
20-04-2009
TPACK names semiconductor industry veteran Colin Macnab as new CEO
Copenhagen Denmark - April 17, 2009 - TPACK (www.tpack.com) announced today that its board of directors has named Colin L.M. Macnab as the new Chief Executive Officer of the company. Mr Macnab brings more than 25 years of semiconductor industry experience with leadership roles in successful startups and large companies to lead TPACK in the next phase of the company's growth Read more
02-04-2009
Teknologien til måling af blodsukker uden brug af blod virker. Nu går RSP Systems ud i tredje
finansieringsrunde for at skaffe kapital til slutspurten. Regnskaberne viser store millionunderskud, men alting kører efter planerne for forskningsvirksomheden RSP Systems i Odense. Om få år skal indtægterne vælte ind, når produktet, en stikfri metode til måling af blodsukker hos sukkersygepatienter, er udviklet færdig og klar til salg. RSP Systems er drømmevirksomheden for ethvert universitet.
Read more
19-02-2009
Proxeon expands commercial operations - confirms key appointments
Odense, Denmark, 18 February 2009. Proxeon confirmed today further expansion of the company's Commercial Operations team through several key appointments.
Dr. Fiona Ford becomes Vice President, Global Sales, bringing to Proxeon more than 20 years of experience in Life Science sales, most recently as Senior Director, Client Business Management at Incyte and Senior Director, Pharmaceutical Business Development with Ciphergen. Dr. Ford stated: "Proxeon has an enviable reputation for technical expertise, innovation and customer support for proteomics workflow. I am really excited to join the team as we expand into the worldwide market. We are all looking forward to significant commercial success in 2009 and beyond."
Read more
16-02-2009
Tillid skaffer lille IT-firma 6 millioner i ny kapital
IT-firmaet aCon, der startede i en kælder hos iværksætteren bag, lykkes med at hente 6 mio. kr. i frisk kapital trods krise og sortsyn. Read more
16-02-2009
Action Pharma’s CEO awarded the Novo Nordisk Prize 2009
Søren Nielsen, CEO of Action Pharma A/S has been awarded the Novo Nordisk Prize 2009.
”With his impressive scientific results Søren Nielsen is placed in the international elite with a very comprehensive scientific production published in high impact research journals” says Professor Jan Fahrenkrug, chairman of the Prize committee at the Novo Nordisk Foundation.
Read more
16-02-2009
Action Pharma recruits Torben J. Laursen to lead the commercialization of the pipeline
Action Pharma A/S has recruited Torben Jung Laursen as Executive Vice President of Business Development. Torben has a solid background in the pharma industry having worked 20 years for companies such as Novo Nordisk, Roche and most recently Alpharma in functions spanning finance, marketing and business development. His last position at Alpharma was as Vice President New Products and Technologies.
Read more
06-02-2009
Consolidation Provides Complete View of Patient Imaging Data for seven hospitals and 35 health clinics in New Orleans
MORTSEL, BE and GREENVILLE, USA - (HealthTech Wire / News) - Agfa HealthCare, a leading provider of IT-enabled workflow and diagnostic imaging solutions, announces today that Ochsner Health System of New Orleans has deployed the company's IMPAX® Data Center. The system, which manages diagnostic image access and distribution across the enterprise, is a leading image management and storage solution for large, multi-site and multi-facility healthcare domains. Read more
06-02-2009
Danish Biotech Company, FCMB, has discovered a breakthrough in risk-free prenatal diagnostic.
Vejle, Denmark (MMD Newswire) December 29, 2008 -- Danish Biotech Company, FCMB, has discovered a breakthrough in risk-free prenatal diagnostic. For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available. FCMB has created a cDNA library originating from fetal cells revealing expression patterns different from maternal blood cells.
Read more
28-10-2008
GeneBio and Proxeon Sign Agreement for Phenyx and ProteinCenter
Geneva, Switzerland and Odense, Denmark – October 28, 2008 - Geneva Bioinformatics (GeneBio) SA and Proxeon today announced an integration and distribution agreement focused on GeneBio’s Phenyx protein identification platform and Proxeon’s ProteinCenterTM data interpretation software. Financial terms of the agreement were not disclosed. Read more
14-10-2008
TPACK appoints new chairman
October 14, 2008, Copenhagen, Denmark: TPACK today announced the appointment of Hassan Parsa as chairman of the board. Mr. Parsa has been a member of the TPACK board for over a year and brings several years of experience in the semiconductor and telecom industry to the position. Read more
25-09-2008
Proxeon and Thermo Fisher Scientific integrate system software
Proxeon adds third major HPLC and MS instrument supplier to the company's list of business partners
Read more
22-09-2008
Fujitsu selects TPACK SoftSilicon solution
September 22, 2008, Copenhagen, Denmark: TPACK today announced that Fujitsu Limited, Japan has signed a long term agreement with TPACK for supply of an advanced SoftSilicon Ethernet over NG-PDH product targeting the Fujitsu award winning FLASHWAVE® series platform.
Read more
10-09-2008
Medotech på milliardmarked
Århusianske Medotech har netop hentet 8 mio. kr. fra sine investorer og skal bruge yderligere 30 mio. kr. senere i år for at udrulle sit grindcare-produkt, der skal få folk, der skærer tænder, til at droppe bideskinnen og simpelthen lære at slappe af i kæbemusklerne. Read more
13-08-2008
Banebrydende samarbejde om tv-løsninger til landets antenneanlæg og bolignet BOXdanmark og Dansk Bredbånd har indgået et stærkt partnerskab, og bliver dermed en større konkurrent til de øvrige aktører på tv-markedet.
Read more17-07-2008
Fluxome Sciences Expands Capital by DKK 100 mio /EUR 13 mio
Copenhagen, Denmark – July 17th, 2008
In a European biotech investment environment under pressure, fast-growing Danish biotech company Fluxome Sciences A/S announces a capital increase of DKK 100 mio/EUR 13 mio.
Read more
09-07-2008
iMotions Hires High Profile COO and Raises $ US 2 Million in Bridge Funding
iMotions - Emotion Technology A/S, the leading developer of emotional response and eye-tracking software, announced today that Peter Schmidt will take over as Director of the Copenhagen office and COO of European Operations. Simultaneously, iMotions' CEO and Co-Founder Peter Hartzbech, has joined the Board of Directors
Read more
17-06-2008
CP Kelco U.S., Inc. and Fluxome Sciences Join Forces in Resveratrol
CP Kelco U.S., Inc., ("CP Kelco") a unit of J.M. Huber Corporation, and Fluxome Sciences A/S, a Copenhagen-based Danish biotechnology company, announced today that they have entered into an agreement to jointly develop and commercialize fermentation derived resveratrol for the dietary supplement, food, beverage, and cosmetics markets Read more
05-06-2008
June 5, 2008, Copenhagen, Denmark: TPACK announced today that Technology Marketing Corporation’s (TMC) Communications Solutions (www.tmcnet.com/comsol) has named the TPWX3192 Carrier Packet Mapper Engine as a recipient of a 2007 Product of the Year Award.
Read more23-05-2008
Major MS suppliers increasingly recognising Proxeon products
Odense, Denmark, 23.05.2008.
Proxeon revealed today that this year's ASMS features a record number of scientific posters utilizing the company's products - a further demonstration that the Proxeon product portfolio is being used across the proteomic workflow.
Read more
28-04-2008
Proxeon today announced today that the company has entered into an OEM agreement with Varian Inc. under which Proxeon's nanoscale liquid chromatography system (EASY-nLCTM) will be available to interface with Varian's 920-MS Triple Quadrupole Fourier Transform Mass Spectrometer (TQ-FTMS). Under the non-exclusive, worldwide agreement, the nano-LC system will be marketed and sold as the Varian 216-LC.
Read more
16-04-2008
Medicon Valley, Copenhagen, Denmark, and Bubendorf/Basel, Switzerland, April 10, 2008 -
Action Pharma A/S and Bachem (SWX: BANB) today announced their cooperation on AP214,
Action Pharma’s lead compound, about to enter Phase 2 clinical trials in post-surgical organ
failure. Since 2002, Bachem has supported Action Pharma by producing the peptide active
ingredient of this drug candidate, by analytical method development, analytical method
validation as well as by regulatory services. For the upcoming Phase 2 clinical trial, Bachem
also supplies finished dosage forms under its Clinalfa® brand. Read more
14-04-2008
Medical Insight: Hospitals can now add complete mobility to their PACS and EMR systems in order to support nomadic clinical workflows.
Read more11-04-2008
TPACK releases the SMARTPACK TPX3103 52 Gbps PBB-TE/T-MPLS/VPLS Carrier Packet Engine, a new SOFTSILICON product providing a flexible Carrier Ethernet switch/traffic manager ASSP.
Read more
11-04-2008
April 9, 2008: Proxeon announced today that the company has released an enhanced version of its proteomics data interpretation software, ProteinCenterTMv.1.5.
Read more07-04-2008
Medotech lancerer et nyudviklet patientapparat, som udsender en ultralav elektrisk impuls, som får kæbemuskulaturen til at slappe af (Artikel fra tidsskriftet "Tandlægebladet, 1. april, 2008)
Read more04-04-2008
Fluxome reaches scale-up phase for bioprocessed resveratrol,
its first product predicted to hit the US market by last quarter of 2008
Read more
12-03-2008
Den globale afmatning har medført, at Inventure Capital har besluttet at udskyde etableringen af den nye iværksætterfond i Vestdanmark på 500 millioner kr. i 1-2 år. Vækstfonden glæder sig over, at IC’s tre fonde, Incuba Venture I, InnFond og Syddansk Kapital fortsat kan videreudvikles samlet.
Read more21-01-2008
Copenhagen, Jan [15] 2008 - Action Pharma A/S, a Danish biotech company dedicated to the discovery and development of novel drugs for the treatment of Type 2 diabetes and other diseases, including organ failure, today announced that it has signed a financing agreement with new and existing investors, raising a total of EUR 15 million.
Read more